The cell biology technology provider, which counts Nikon and Varian Medical among its investors, has raised about $215m in venture funding.
US-based digital cell biology developer Berkeley Lights has filed to raise up to $100m in an initial public offering that would enable corporates Nikon and Varian Medical Systems to exit.
Berkeley Lights has created technology that captures single-cell specific information to support the development of cell-based products including antibody therapeutics or cell therapies.
The company made an $18.3m net loss in 2019 from $56.7m in revenue and plans to channel some of the IPO takings into research and development…
